Proveca Ltd is a pharmaceutical company specialising in identifying, researching and licensing off-patent medicines with unmet priority health care needs, with a focus on the paediatric market. By developing the necessary formulations and clinical data required to obtain a Paediatric Use Marketing Authorisation (PUMA) these drugs will benefit froma period of 10 years' market protection (8 years of data and market protection plus 2 further years of market protection). In addition, where appropriate, Orphan Drug status (Orphan Drug) will be sought which affords a period of 10 years' market exclusivity to run concurrently.Value will be realised through commercialisation of the licensed medicine or an outright sale of the licence to a larger pharmaceutical company.

Biotechnology

Health Care

Pharmaceutical

Proveca Ltd

Simon Bryson

Callum Smith

Sara Tesfay

Lothar Schlüter

Laura Prosser

Peter McBride

H K Wilmshurst

Helen Wilmshurst

Daniel Margetson

Clare Gleeson

The Medical Affairs Team at Proveca Ltd plays a critical role in bridging the gap between clinical development and commercialisation. They are responsible for providing medical expertise to support the development of off-patent medicines, engaging with healthcare professionals to communicate the benefits and safety of paediatric formulations, and ensuring compliance with regulatory standards. Additionally, the team collaborates with other departments to generate and disseminate scientific evidence that supports the company’s therapeutic strategies and initiatives.

Medical Affairs Team

Business Operations and Strategy

Operations Team

Leadership Team

Medical Affairs Team

About

Team members

Other teams at Proveca Ltd

Business Operations and Strategy

Operations Team

Leadership Team